Citizens Financial Group’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-8
Closed -$1K 397
2020
Q2
$1K Buy
+8
New +$1K ﹤0.01% 1027